Literature DB >> 28432982

Demyelinating polyradiculoneuropathy under combined BRAF/MEK inhibitors.

Perrine Devic1, Mona Amini-Adle2, Jean-Philippe Camdessanché3, Stéphane Dalle4.   

Abstract

Entities:  

Keywords:  Chronic inflammatory demyelinating polyneuropathy; Guillain–Barre syndrome; Immunotherapy; Melanoma

Mesh:

Substances:

Year:  2017        PMID: 28432982     DOI: 10.1016/j.ejca.2017.03.018

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

Review 1.  Neurologic complications of immune checkpoint inhibitors.

Authors:  Alexandra M Haugh; John C Probasco; Douglas B Johnson
Journal:  Expert Opin Drug Saf       Date:  2020-03-11       Impact factor: 4.250

Review 2.  Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature.

Authors:  Chiara Demichelis; Andrea Balestra; Caterina Lapucci; Angela Zuppa; Stefano G Grisanti; Valeria Prada; Giampaola Pesce; Ilaria Grasso; Paola Queirolo; Angelo Schenone; Luana Benedetti; Marina Grandis
Journal:  Neurol Sci       Date:  2020-08-11       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.